Yesterday (9/13/16) Glooko announced that they were merging with Diasend, which will make them a powerhouse in the Diabetic community. If you have followed this blog for any length of time, you will know that I was in on the ground floor beta testing for Glooko. So for someone like me this is the most amazing news, having watched this company over the last 3 or 4 years evolve to such a point that they can acquire another company is mind boggling to me.
Now if you are not sure about what Glooko or Diasend is, they are reporting tools for collecting data about your diabetes management. With Glooko in the past, you could upload your meter to the program and it gave you comprehensive information and graphical charts that you could then share or print out. Diasend has been the industry standard for health care.
They provided you with a location to upload your information from things like CGM’s (Continuous Glucose Monitors) to insulin pumps and even glucose meters.
Each of the two companies being pioneer’s in their industries. This now means that people across the globe will have the best support in monitoring and recording their information and sharing it with their health care professionals.
I have only just started using Diasend since being placed on a pump 4 months ago. I like some of their features, but I still held true to Glooko.
Now that they have merged it means that I no longer have to switch between the two programs when im updating my patient file with my Diabetes doctor, and educator.
In an announcement that came via e-mail Glooko made the announcement:
“We are excited to announce our merger with Diasend, to accelerate our mission to make diabetes management easier! As a combined entity, we unite under the Glooko name and serve 4000 diabetes clinics in 23 countries across 15 languages, impacting tens of millions of people with diabetes. The joint platform downloads data from more than 160 different devices – including glucose meters, insulin pumps, continuous glucose monitors (CGMs) and activity trackers, in total covering over 95% of diabetes devices used worldwide.”